Abbott Laboratories (ABT) Non-Current Assets (2009 - 2026)

Abbott Laboratories' Non-Current Assets history runs 18 years deep, the most recent figure standing at $84.9 billion for Q1 2026.

• In Q1 2026, Non-Current Assets rose 45.67% year-over-year to $84.9 billion; the TTM figure through Mar 2026 stood at $264.5 billion (up 22.17% YoY), while the FY2025 annual figure was $60.7 billion, up 5.12% from the prior year.
• Non-Current Assets came in at $84.9 billion for Q1 2026 at Abbott Laboratories, up from $60.7 billion in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $84.9 billion in Q1 2026 to a low of -$22.3 billion in Q4 2022.
• A 5-year average of $50.3 billion and a median of $50.5 billion in 2023 frame the typical range for Non-Current Assets.
• Across the five-year window, Non-Current Assets slumped 270.54% in 2022 and soared 326.24% in 2023, its largest moves.
• Abbott Laboratories' Non-Current Assets stood at -$22.3 billion in 2022, then jumped by 326.24% to $50.5 billion in 2023, then climbed by 14.27% to $57.8 billion in 2024, then increased by 5.12% to $60.7 billion in 2025, then jumped by 39.86% to $84.9 billion in 2026.
• According to Business Quant data, Non-Current Assets over the past three periods registered $84.9 billion, $60.7 billion, and $59.3 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison